Bayer | BAYN - Net Income

Stock Price
42.59
Daily Change
0.25 0.58%
Monthly
-8.15%
Yearly
84.87%
Q1 Forecast
42.20

Bayer reported EUR-963M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Air Liquide EUR 1.72B 84.3M Dec/2025
Akzo Nobel EUR 598M 792M Dec/2025
Alcon AG USD 237M 61M Sep/2025
Amarin USD -7.74M 6.4M Sep/2025
Arkema EUR 35M 12M Sep/2025
AstraZeneca USD 2.33B 207M Dec/2025
BASF EUR 172M 93M Sep/2025
Bayer EUR -963M 764M Sep/2025
Beiersdorf EUR 552M 222M Jun/2025
Corteva USD -552M 232M Dec/2025
Covestro EUR -47M 12M Sep/2025
Essilor EUR 928M 459M Dec/2025
Fresenius EUR 344M 14M Sep/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Genmab DKK 336M 141M Jun/2025
Givaudan CHF 294M 150M Jun/2024
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 126.96M 9.9M Sep/2025
Henkel EUR 1.11B 132M Jun/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Johnson Matthey GBP -18M 93M Dec/2025
Linde USD 1.93B 163M Sep/2025
Lonza CHF 307M 22M Dec/2024
Merck EUR 902M 250M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Nutrien USD 571M 107M Dec/2025
Philips EUR 395M 211M Dec/2025
PPG Industries USD 300M 153M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
SAP EUR 1.85B 158M Dec/2025
Solvay EUR -95M 129M Dec/2025
UCB EUR 857M 649M Dec/2024
Umicore EUR 136.7M 140.65M Jun/2025
Vinci EUR 3.01B 1.11B Dec/2025